MITCHELL J FUHRMAN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease VOORHEES, NJ NPI 1619969474

General Payments — all program years on this page

$1,772.54

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 114
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $262.64 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $262.6416

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $413.2532
2019 $474.8633
2020 $172.435
2021 $30.772
2022 $65.864
2023 $352.7322
2024 $262.6416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078096806 Janssen Pharmaceuticals, Inc $17.88 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078096818 Janssen Pharmaceuticals, Inc $18.46 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080666373 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.88 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081708627 Lexicon Pharmaceuticals, Inc. $18.02 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870063 Novartis Pharmaceuticals Corporation $16.90 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086870067 Novartis Pharmaceuticals Corporation $16.87 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114051280 Regeneron Healthcare Solutions, Inc. $15.46 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115638561 Amgen Inc. $18.42 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115638575 Amgen Inc. $18.09 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115638588 Amgen Inc. $14.38 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131755256 PFIZER INC. $17.51 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131935980 PFIZER INC. $13.36 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141846077 Merck Sharp & Dohme LLC $13.96 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141920320 Merck Sharp & Dohme LLC $13.09 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154877205 Kiniksa Pharmaceuticals International, plc $16.35 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154877221 Kiniksa Pharmaceuticals International, plc $15.01 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.